Skip to main content
Erschienen in: Quality of Life Research 11/2019

09.08.2019

Cancer survivor perspectives on sharing patient-generated health data with central cancer registries

Erschienen in: Quality of Life Research | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Central cancer registries collect data and provide population-level statistics that can be tracked over time; yet registries may not capture the full range of clinically relevant outcomes. Patient-generated health data (PGHD) include health/treatment history, biometrics, and patient-reported outcomes (PROs). Collection of PGHD would broaden registry outcomes to better inform research, policy, and care. However, this is dependent on the willingness of patients to share such data. This study examines cancer survivors’ perspectives about sharing PGHD with central cancer registries.

Methods

Three U.S. central registries sampled colorectal, non-Hodgkin lymphoma, and metastatic breast cancer survivors 1–4 years after diagnosis, recruiting them via mail to participate in one of seven focus groups (n = 52). Group discussions were recorded, transcribed, and thematically analyzed.

Results

Most survivor-participants were unaware of the existence of registries. After having registries explained, all participants expressed their willingness to share PGHD with them if treated confidentially. Participants were willing to provide information on a variety of topics (e.g., medical history, medications, symptoms, financial difficulties, quality of life, biometrics, nutrition, exercise, and mental health), with a focus on long-term effects of cancer and its treatment. Participants’ preferred mode for providing data varied. Participants were also interested in receiving information from registries.

Conclusions

Our results suggest that registry-based collection of PGHD is acceptable to most cancer survivors and could facilitate registry-based efforts to collect PGHD/PROs. Central cancer registry-based collection of PGHD/PROs, especially on long-term effects, could enhance registry support of cancer control efforts including research and population health management.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
3.
Zurück zum Zitat Kindig, D., & Stoddart, G. (2003). What is population health? American Journal of Public Health, 93(3), 380–383.CrossRef Kindig, D., & Stoddart, G. (2003). What is population health? American Journal of Public Health, 93(3), 380–383.CrossRef
11.
Zurück zum Zitat National Comprehensive Cancer Network. (2018). NCCN clinical practice guidelines in oncology: Cancer-related fatigue version 2.2018. Fort Washington: National Comprehensive Cancer Network. National Comprehensive Cancer Network. (2018). NCCN clinical practice guidelines in oncology: Cancer-related fatigue version 2.2018. Fort Washington: National Comprehensive Cancer Network.
12.
Zurück zum Zitat National Comprehensive Cancer Network. (2018). NCCN clinical practice guidelines in oncology: Adult cancer pain version 1.2018. Fort Washington: National Comprehensive Cancer Network. National Comprehensive Cancer Network. (2018). NCCN clinical practice guidelines in oncology: Adult cancer pain version 1.2018. Fort Washington: National Comprehensive Cancer Network.
13.
Zurück zum Zitat National Comprehensive Cancer Network. (2018). NCCN clinical practice guidelines in oncology: Distress management version 2.2018. Fort Washington: National Comprehensive Cancer Network. National Comprehensive Cancer Network. (2018). NCCN clinical practice guidelines in oncology: Distress management version 2.2018. Fort Washington: National Comprehensive Cancer Network.
14.
Zurück zum Zitat National Quality Forum. (2013). Patient reported outcomes (PROs) in performance measurement. Washington, DC: NQF. National Quality Forum. (2013). Patient reported outcomes (PROs) in performance measurement. Washington, DC: NQF.
16.
Zurück zum Zitat Centers for Medicare & Medicaid Services. (2018). Blueprint for the CMS measures management system (version 14.0). Washington, DC: CMS. Centers for Medicare & Medicaid Services. (2018). Blueprint for the CMS measures management system (version 14.0). Washington, DC: CMS.
17.
Zurück zum Zitat European Medicines Agency. (2016). The guideline on the evaluation of anticancer medicinal products in man: Appendix 2 The use of patient-reported outcome (PRO) measures in oncology studies. London, UK: EMA. European Medicines Agency. (2016). The guideline on the evaluation of anticancer medicinal products in man: Appendix 2 The use of patient-reported outcome (PRO) measures in oncology studies. London, UK: EMA.
18.
19.
Zurück zum Zitat Kluetz, P. G., Chingos, D. T., Basch, E. M., & Mitchell, S. A. (2016). Patient-reported outcomes in cancer clinical trials: Measuring symptomatic adverse events with the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). American Society of Clinical Oncology Educational Book, 35, 67–73. https://doi.org/10.1200/edbk_159514.CrossRefPubMed Kluetz, P. G., Chingos, D. T., Basch, E. M., & Mitchell, S. A. (2016). Patient-reported outcomes in cancer clinical trials: Measuring symptomatic adverse events with the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). American Society of Clinical Oncology Educational Book, 35, 67–73. https://​doi.​org/​10.​1200/​edbk_​159514.CrossRefPubMed
21.
Zurück zum Zitat Barile, J. P., Reeve, B. B., Smith, A. W., Zack, M. M., Mitchell, S. A., Kobau, R., et al. (2013). Monitoring population health for Healthy People 2020: Evaluation of the NIH PROMIS(R) Global Health, CDC Healthy Days, and satisfaction with life instruments. Quality of Life Research, 22(6), 1201–1211. https://doi.org/10.1007/s11136-012-0246-z.CrossRefPubMed Barile, J. P., Reeve, B. B., Smith, A. W., Zack, M. M., Mitchell, S. A., Kobau, R., et al. (2013). Monitoring population health for Healthy People 2020: Evaluation of the NIH PROMIS(R) Global Health, CDC Healthy Days, and satisfaction with life instruments. Quality of Life Research, 22(6), 1201–1211. https://​doi.​org/​10.​1007/​s11136-012-0246-z.CrossRefPubMed
22.
24.
Zurück zum Zitat Kent, E. E., Malinoff, R., Rozjabek, H. M., Ambs, A., Clauser, S. B., Topor, M. A., et al. (2016). Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) linked data resource for patient-reported outcomes research in older adults with cancer. Journal of the American Geriatrics Society, 64(1), 186–192. https://doi.org/10.1111/jgs.13888.CrossRefPubMed Kent, E. E., Malinoff, R., Rozjabek, H. M., Ambs, A., Clauser, S. B., Topor, M. A., et al. (2016). Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) linked data resource for patient-reported outcomes research in older adults with cancer. Journal of the American Geriatrics Society, 64(1), 186–192. https://​doi.​org/​10.​1111/​jgs.​13888.CrossRefPubMed
25.
Zurück zum Zitat White House Cancer Moonshot Task Force. (2016). Report of the cancer moonshot task force. White House Cancer Moonshot Task Force. (2016). Report of the cancer moonshot task force.
26.
Zurück zum Zitat Gliklich, R. E., Dreyer, N. A., & Leavy, M. B. (2014). Registries for evaluating patient outcomes: A user’s guide (3rd ed.). Rockville, MD: Agency for Healthcare Research and Quality (US). Gliklich, R. E., Dreyer, N. A., & Leavy, M. B. (2014). Registries for evaluating patient outcomes: A user’s guide (3rd ed.). Rockville, MD: Agency for Healthcare Research and Quality (US).
28.
Zurück zum Zitat Shapiro, M., Johnston, D., Wald, J., & Mon, D. (2012). Patient-generated health data: White paper prepared for the office of the national coordinator for health information technology. Research Triangle Park, NC: RTI International. Shapiro, M., Johnston, D., Wald, J., & Mon, D. (2012). Patient-generated health data: White paper prepared for the office of the national coordinator for health information technology. Research Triangle Park, NC: RTI International.
31.
Zurück zum Zitat Rea, L. M., & Parker, R. A. (1992). Designing and conducting survey research: A comprehensive guide. San Francisco, CA: Jossey-Bass Publishers. Rea, L. M., & Parker, R. A. (1992). Designing and conducting survey research: A comprehensive guide. San Francisco, CA: Jossey-Bass Publishers.
32.
Zurück zum Zitat Krueger, R. A., & Casey, M. A. (2015). Focus groups: A practical guide for applied research (5th ed.). Thousand Oaks, CA: Sage. Krueger, R. A., & Casey, M. A. (2015). Focus groups: A practical guide for applied research (5th ed.). Thousand Oaks, CA: Sage.
40.
Zurück zum Zitat Zafar, S. Y., & Abernethy, A. P. (2013). Financial toxicity, Part I: A new name for a growing problem. Oncology, 27(2), 80–81, 149. Zafar, S. Y., & Abernethy, A. P. (2013). Financial toxicity, Part I: A new name for a growing problem. Oncology, 27(2), 80–81, 149.
46.
Zurück zum Zitat Reeve, B. B., Wyrwich, K. W., Wu, A. W., Velikova, G., Terwee, C. B., Snyder, C. F., et al. (2013). ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Quality of Life Research, 22(8), 1889–1905. https://doi.org/10.1007/s11136-012-0344-y.CrossRefPubMed Reeve, B. B., Wyrwich, K. W., Wu, A. W., Velikova, G., Terwee, C. B., Snyder, C. F., et al. (2013). ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Quality of Life Research, 22(8), 1889–1905. https://​doi.​org/​10.​1007/​s11136-012-0344-y.CrossRefPubMed
Metadaten
Titel
Cancer survivor perspectives on sharing patient-generated health data with central cancer registries
Publikationsdatum
09.08.2019
Erschienen in
Quality of Life Research / Ausgabe 11/2019
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-019-02263-0

Weitere Artikel der Ausgabe 11/2019

Quality of Life Research 11/2019 Zur Ausgabe